Cite
HARVARD Citation
Hibi, T. et al. (2016). Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study. Medicine. 95 (24), pp. e3863-. [Online].